Try our Advanced Search for more refined results
Duncan v. Vical Incorporated et al
Case Number:
3:13-cv-02628
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
March 10, 2015
Biopharma Co. Didn't Lie About Cancer Drug Progress: Judge
A California federal judge on Monday dismissed a proposed shareholder class action accusing experimental drug developer Vical Inc. of misleading investors about its cancer drug, describing the complaint as an attempt to punish a corporation and its officers for expressing incorrect opinions.
-
October 31, 2013
Biopharma Co. Misled Investors On Cancer Drug Progress: Suit
Vical Inc., which researches and develops biopharmaceutical products for the prevention and treatment of serious diseases, on Wednesday was hit with a putative class action in California federal court by a shareholder who says the company made false statements about the progress of cancer drug Allovectin-7.